The use of tenofovir and alteration of kidney function in people living with HIV/AIDS
Autor(a) principal: | |
---|---|
Data de Publicação: | 2022 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Research, Society and Development |
Texto Completo: | https://rsdjournal.org/index.php/rsd/article/view/24502 |
Resumo: | This study aims to analyze the alteration in the renal function of PLHIV who used Tenofovir as part of their antiretroviral treatment. This was an observational epidemiological study, through a review of 86 records of PLHIV using Tenofovir, where a survey of data on creatinine values of patients was carried out. A data collection form covering demographic, clinical and laboratory data was used. The estimated Glomerular Filtration Rate was calculated by the CKD-EPI formula. With the results of this study, it was observed that so far, there are no medications free of adverse effects, but it was seen that in addition to monitoring the renal function of patients, it is necessary to prioritize the control of the patient's underlying diseases, as well as the maintenance of an undetectable viral load, a fact that was found in this study, when using TDF as ARVT. |
id |
UNIFEI_9e78f1b1e52e2988328b531130cb101e |
---|---|
oai_identifier_str |
oai:ojs.pkp.sfu.ca:article/24502 |
network_acronym_str |
UNIFEI |
network_name_str |
Research, Society and Development |
repository_id_str |
|
spelling |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDSEl uso de tenofovir y la alteración de la función renal en personas que viven con VIH/SIDAO uso do tenofovir e alteração da função renal em pessoas vivendo com HIV/AIDSHIVCreatininaTenofovir.HIVCreatinineTenofovir.VIHCreatininaTenofovir.This study aims to analyze the alteration in the renal function of PLHIV who used Tenofovir as part of their antiretroviral treatment. This was an observational epidemiological study, through a review of 86 records of PLHIV using Tenofovir, where a survey of data on creatinine values of patients was carried out. A data collection form covering demographic, clinical and laboratory data was used. The estimated Glomerular Filtration Rate was calculated by the CKD-EPI formula. With the results of this study, it was observed that so far, there are no medications free of adverse effects, but it was seen that in addition to monitoring the renal function of patients, it is necessary to prioritize the control of the patient's underlying diseases, as well as the maintenance of an undetectable viral load, a fact that was found in this study, when using TDF as ARVT.Este estudio tiene como objetivo analizar la alteración en la función renal de las PVVIH que usaron Tenofovir como parte de su tratamiento antirretroviral. Se trata de un estudio epidemiológico observacional, a través de una revisión de 86 registros de PVVIH utilizando Tenofovir, donde se realizó una encuesta de datos sobre los valores de creatinina de los pacientes. Se utilizó un formulario de recopilación de datos que incluía datos demográficos, clínicos y de laboratorio. La tasa de filtración glomerular estimada se calculó mediante la fórmula CKD-EPI. Con los resultados de este estudio, se observó que hasta el momento, no existen medicamentos libres de efectos adversos, pero se vio que además de monitorear la función renal de los pacientes, es necesario priorizar el control de las enfermedades de base del paciente, así como el mantenimiento de una carga viral indetectable, hecho que se encontró en este estudio, al utilizar TDF como TAR.Este estudo tem como objetivo analisar a alteração da função renal de PVHIV que fizeram uso de Tenofovir como parte do tratamento antirretroviral. Tratou-se de um estudo epidemiológico observacional, por meio da revisão de 86 prontuários de PVHIV em uso de Tenofovir, onde foi realizado um levantamento dos dados sobre valores de creatinina dos pacientes. Foi utilizado uma ficha de coleta de dados abrangendo dados demográficos, clínicos e laboratoriais. A Taxa de Filtração Glomerular estimada foi calculada pela fórmula CKD-EPI. Com os resultados deste estudo, observou-se que até o momento, não existem medicações isentas de efeitos adversos, porém viu-se que além de monitorar a função renal dos pacientes, é preciso priorizar o controle das doenças de base do paciente, assim como a manutenção da carga viral indetectável, fato que foi encontrado neste estudo, ao se utilizar o TDF como TARV.Research, Society and Development2022-01-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2450210.33448/rsd-v11i1.24502Research, Society and Development; Vol. 11 No. 1; e4911124502Research, Society and Development; Vol. 11 Núm. 1; e4911124502Research, Society and Development; v. 11 n. 1; e49111245022525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/24502/21616Copyright (c) 2022 Ananda Soares de Brito Freire; Francisco de Assis Oliveira Andrade Filho; Carlos Gilvan Nunes de Carvalhohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessFreire, Ananda Soares de BritoAndrade Filho, Francisco de Assis OliveiraCarvalho, Carlos Gilvan Nunes de2022-01-16T18:08:18Zoai:ojs.pkp.sfu.ca:article/24502Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:43:01.989043Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false |
dc.title.none.fl_str_mv |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS El uso de tenofovir y la alteración de la función renal en personas que viven con VIH/SIDA O uso do tenofovir e alteração da função renal em pessoas vivendo com HIV/AIDS |
title |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
spellingShingle |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS Freire, Ananda Soares de Brito HIV Creatinina Tenofovir. HIV Creatinine Tenofovir. VIH Creatinina Tenofovir. |
title_short |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
title_full |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
title_fullStr |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
title_full_unstemmed |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
title_sort |
The use of tenofovir and alteration of kidney function in people living with HIV/AIDS |
author |
Freire, Ananda Soares de Brito |
author_facet |
Freire, Ananda Soares de Brito Andrade Filho, Francisco de Assis Oliveira Carvalho, Carlos Gilvan Nunes de |
author_role |
author |
author2 |
Andrade Filho, Francisco de Assis Oliveira Carvalho, Carlos Gilvan Nunes de |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Freire, Ananda Soares de Brito Andrade Filho, Francisco de Assis Oliveira Carvalho, Carlos Gilvan Nunes de |
dc.subject.por.fl_str_mv |
HIV Creatinina Tenofovir. HIV Creatinine Tenofovir. VIH Creatinina Tenofovir. |
topic |
HIV Creatinina Tenofovir. HIV Creatinine Tenofovir. VIH Creatinina Tenofovir. |
description |
This study aims to analyze the alteration in the renal function of PLHIV who used Tenofovir as part of their antiretroviral treatment. This was an observational epidemiological study, through a review of 86 records of PLHIV using Tenofovir, where a survey of data on creatinine values of patients was carried out. A data collection form covering demographic, clinical and laboratory data was used. The estimated Glomerular Filtration Rate was calculated by the CKD-EPI formula. With the results of this study, it was observed that so far, there are no medications free of adverse effects, but it was seen that in addition to monitoring the renal function of patients, it is necessary to prioritize the control of the patient's underlying diseases, as well as the maintenance of an undetectable viral load, a fact that was found in this study, when using TDF as ARVT. |
publishDate |
2022 |
dc.date.none.fl_str_mv |
2022-01-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/24502 10.33448/rsd-v11i1.24502 |
url |
https://rsdjournal.org/index.php/rsd/article/view/24502 |
identifier_str_mv |
10.33448/rsd-v11i1.24502 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rsdjournal.org/index.php/rsd/article/view/24502/21616 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Research, Society and Development |
publisher.none.fl_str_mv |
Research, Society and Development |
dc.source.none.fl_str_mv |
Research, Society and Development; Vol. 11 No. 1; e4911124502 Research, Society and Development; Vol. 11 Núm. 1; e4911124502 Research, Society and Development; v. 11 n. 1; e4911124502 2525-3409 reponame:Research, Society and Development instname:Universidade Federal de Itajubá (UNIFEI) instacron:UNIFEI |
instname_str |
Universidade Federal de Itajubá (UNIFEI) |
instacron_str |
UNIFEI |
institution |
UNIFEI |
reponame_str |
Research, Society and Development |
collection |
Research, Society and Development |
repository.name.fl_str_mv |
Research, Society and Development - Universidade Federal de Itajubá (UNIFEI) |
repository.mail.fl_str_mv |
rsd.articles@gmail.com |
_version_ |
1797052760734040064 |